Published in PLoS One on May 15, 2015
Rheumatology around the world: perspectives from Australia and New Zealand. Arthritis Res Ther (2017) 0.75
Intake of sugar-sweetened beverages and weight gain: a systematic review. Am J Clin Nutr (2006) 13.19
Changes in diet and lifestyle and long-term weight gain in women and men. N Engl J Med (2011) 12.29
Effects of soft drink consumption on nutrition and health: a systematic review and meta-analysis. Am J Public Health (2007) 10.22
Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum (1977) 8.55
Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis. Diabetes Care (2010) 8.52
Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest (2009) 7.09
Sugar-sweetened beverages, obesity, type 2 diabetes mellitus, and cardiovascular disease risk. Circulation (2010) 6.86
Dietary sugars intake and cardiovascular health: a scientific statement from the American Heart Association. Circulation (2009) 5.82
Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease. Am J Clin Nutr (2007) 5.28
Sweetened beverage consumption, incident coronary heart disease, and biomarkers of risk in men. Circulation (2012) 4.24
Sweetened beverage consumption and risk of coronary heart disease in women. Am J Clin Nutr (2009) 3.90
Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study. BMJ (2008) 3.71
2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis. Arthritis Care Res (Hoboken) (2012) 2.83
Effects of food form on appetite and energy intake in lean and obese young adults. Int J Obes (Lond) (2007) 2.65
Sucrose-sweetened beverages increase fat storage in the liver, muscle, and visceral fat depot: a 6-mo randomized intervention study. Am J Clin Nutr (2011) 2.47
Low to moderate sugar-sweetened beverage consumption impairs glucose and lipid metabolism and promotes inflammation in healthy young men: a randomized controlled trial. Am J Clin Nutr (2011) 2.34
Metabolic effects of dietary fructose. FASEB J (1990) 2.01
Does food group consumption vary by differences in socioeconomic, demographic, and lifestyle factors in young adults? The Bogalusa Heart Study. J Am Diet Assoc (2007) 1.99
Sugar and fat bingeing have notable differences in addictive-like behavior. J Nutr (2009) 1.77
Moderate amounts of fructose consumption impair insulin sensitivity in healthy young men: a randomized controlled trial. Diabetes Care (2012) 1.76
Dietary pattern change and acculturation of Chinese Americans in Pennsylvania. J Am Diet Assoc (2004) 1.64
Interrelationships of added sugars intake, socioeconomic status, and race/ethnicity in adults in the United States: National Health Interview Survey, 2005. J Am Diet Assoc (2009) 1.51
Preventing cancer, cardiovascular disease, and diabetes: a common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association. Diabetes Care (2004) 1.49
Effect of sucrose on inflammatory markers in overweight humans. Am J Clin Nutr (2005) 1.48
Fructose-rich beverages and risk of gout in women. JAMA (2010) 1.42
Self-reported sugar-sweetened beverage intake among college students. Obesity (Silver Spring) (2006) 1.39
Chronic diseases and dietary changes in relation to Korean Americans' length of residence in the United States. J Am Diet Assoc (2007) 1.22
Effects of high-fructose corn syrup and sucrose on the pharmacokinetics of fructose and acute metabolic and hemodynamic responses in healthy subjects. Metabolism (2011) 1.15
Dietary intakes and health-related behaviours of Korean American women born in the USA and Korea: the Multiethnic Cohort Study. Public Health Nutr (2005) 1.11
Population-specific influence of SLC2A9 genotype on the acute hyperuricaemic response to a fructose load. Ann Rheum Dis (2013) 1.08
The renal urate transporter SLC17A1 locus: confirmation of association with gout. Arthritis Res Ther (2012) 1.08
Sugar-sweetened beverage consumption: a risk factor for prevalent gout with SLC2A9 genotype-specific effects on serum urate and risk of gout. Ann Rheum Dis (2013) 1.04
Consumption of sugar-sweetened beverages among adults with type 2 diabetes. Diabetes Care (2011) 0.93
Diet and physical activity patterns of urban American Indian women. Am J Health Promot (1999) 0.91
Health research with children. N Z Bioeth J (2000) 0.77
Urate crystal deposition in asymptomatic hyperuricaemia and symptomatic gout: a dual energy CT study. Ann Rheum Dis (2015) 1.67
Sugar-sweetened beverage consumption: a risk factor for prevalent gout with SLC2A9 genotype-specific effects on serum urate and risk of gout. Ann Rheum Dis (2013) 1.04
Gout. Lancet (2016) 0.97
Mendelian randomization analysis associates increased serum urate, due to genetic variation in uric acid transporters, with improved renal function. Kidney Int (2013) 0.93
Impaired response or insufficient dosage? Examining the potential causes of "inadequate response" to allopurinol in the treatment of gout. Semin Arthritis Rheum (2014) 0.91
Safety profile of anti-gout agents: an update. Curr Opin Rheumatol (2014) 0.86
Hydrogen sulfide acts as a pro-inflammatory mediator in rheumatic disease. Int J Rheum Dis (2014) 0.85
Development of a patient-reported outcome measure of tophus burden: the Tophus Impact Questionnaire (TIQ-20). Ann Rheum Dis (2014) 0.83
Does midlife obesity really lower dementia risk? Lancet Diabetes Endocrinol (2015) 0.83
Modulation of genetic associations with serum urate levels by body-mass-index in humans. PLoS One (2015) 0.83
Mutations in the zinc finger protein gene, ZNF469, contribute to the pathogenesis of keratoconus. Invest Ophthalmol Vis Sci (2014) 0.82
Mendelian randomization analysis to examine for a causal effect of urate on bone mineral density. J Bone Miner Res (2015) 0.80
Hyperuricaemia: contributions of urate transporter ABCG2 and the fractional renal clearance of urate. Ann Rheum Dis (2015) 0.77
The genetics of gout: towards personalised medicine? BMC Med (2017) 0.77
GWAS of clinically defined gout and subtypes identifies multiple susceptibility loci that include urate transporter genes. Ann Rheum Dis (2016) 0.76
Developing a Tailored Smoking Cessation Intervention for Rheumatoid Arthritis Patients. Musculoskeletal Care (2015) 0.76
ABCG2 polymorphisms in gout: insights into disease susceptibility and treatment approaches. Pharmgenomics Pers Med (2017) 0.75
Population-specific association between ABCG2 variants and tophaceous disease in people with gout. Arthritis Res Ther (2017) 0.75
The Toll-Like Receptor 4 (TLR4) Variant rs2149356 and Risk of Gout in European and Polynesian Sample Sets. PLoS One (2016) 0.75
Lack of direct evidence for natural selection at the candidate thrifty gene locus, PPARGC1A. BMC Med Genet (2016) 0.75
Urate crystal deposition and bone erosion in gout: 'inside-out' or 'outside-in'? A dual-energy computed tomography study. Arthritis Res Ther (2016) 0.75
Lack of Evidence that Soluble Urate Directly Influences Bone Remodelling: A Laboratory and Clinical Study. Calcif Tissue Int (2017) 0.75
Systematic genetic analysis of early-onset gout: ABCG2 is the only associated locus. Rheumatology (Oxford) (2020) 0.75
Gout and the COVID-19 pandemic. Curr Opin Rheumatol (2022) 0.75
Influence of genetic variants on renal uric acid handling in response to frusemide: an acute intervention study. RMD Open (2017) 0.75
Gout. Nat Rev Dis Prim (2019) 0.75
Expression of the genes facilitating methotrexate action within subcutaneous rheumatoid nodules. Clin Exp Rheumatol (2017) 0.75
Testing the Validity of Taxonic Schizotypy Using Genetic and Environmental Risk Variables. Schizophr Bull (2017) 0.75
Exploring perceptions of a rheumatoid arthritis-specific smoking cessation programme. Musculoskeletal Care (2017) 0.75
Frequency of CYP2C9 polymorphisms in Polynesian people and potential relevance to management of gout with benzbromarone. Joint Bone Spine (2013) 0.75
Clinical and genetic features of diuretic-associated gout: a case-control study. Rheumatology (Oxford) (2016) 0.75
Multiple common and rare variants of ABCG2 cause gout. RMD Open (2017) 0.75
Major unanswered questions in the clinical gout field. Curr Opin Rheumatol (2016) 0.75
Individualising the Dose of Allopurinol in Patients with Gout. Br J Clin Pharmacol (2017) 0.75
Simplification of a pharmacokinetic model for red blood cell methotrexate disposition. Eur J Clin Pharmacol (2015) 0.75
Performance of gout definitions for genetic epidemiological studies: analysis of UK Biobank. Arthritis Res Ther (2017) 0.75
Pacific Populations, Metabolic Disease and 'Just-So Stories': A Critique of the 'Thrifty Genotype' Hypothesis in Oceania. Ann Hum Genet (2015) 0.75
Functional non-synonymous variants of ABCG2 and gout risk. Rheumatology (Oxford) (2017) 0.75
Association analysis of the beta-3 adrenergic receptor Trp64Arg (rs4994) polymorphism with urate and gout. Rheumatol Int (2015) 0.75
Allopurinol Dose Reductions Based on Creatinine Alert Redesign System. Am J Med (2016) 0.75